Benzinga · Sep 25, 2026
Akamai, Atlas Energy Solutions, People And Other Big Stocks Moving Higher On Friday
U.S. stocks rose Friday; Akamai jumped 8.1% on an $11.6B Anthropic cloud deal, while Atlas Energy, Almonty and others posted strong gains.
YD
NASDAQ · YDES
YD Bio Limited Ordinary Shares
Healthcare · Biotechnology
$6.40
Up+$0.36 (+5.51%)
Updated Nov 4, 2026, 8:08 PM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 894.92M
- P/E ratio
- -14.54
- Dividend yield
- 0.00%
- 52-week range
- $1.70 – $8.77
- Volume
- 23.4K
- Avg. volume
- 92.84K
Price performance · YDES
YDES price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
YDES closed at $6.40 after 21 trading sessions, up 3.98% for the selected period.
- Last close
- $6.40
- Period change
- +3.98%
- Period low
- $4.24
- Period high
- $6.74
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $5.81 | $6.48 | $5.81 | $6.395 | 23.4K |
| Nov 2, 2026 | $5.90 | $6.34 | $5.69 | $5.97 | 180.24K |
| Oct 30, 2026 | $5.99 | $6.10 | $5.67 | $5.94 | 47.35K |
| Oct 29, 2026 | $6.31 | $6.60 | $5.80 | $5.87 | 96.18K |
| Oct 28, 2026 | $6.04 | $6.4955 | $5.92 | $6.28 | 283.93K |
| Oct 27, 2026 | $5.30 | $6.15 | $5.10 | $6.04 | 47.16K |
| Oct 26, 2026 | $4.96 | $5.4295 | $4.85 | $5.29 | 59.78K |
| Oct 23, 2026 | $4.28 | $5.10 | $4.135 | $4.95 | 105.14K |
| Oct 22, 2026 | $5.85 | $6.04 | $4.15 | $4.24 | 180.44K |
| Oct 21, 2026 | $5.89 | $6.30 | $5.5995 | $5.77 | 144.1K |
| Oct 20, 2026 | $6.08 | $6.565 | $5.61 | $5.84 | 178.14K |
| Oct 19, 2026 | $5.92 | $6.26 | $5.46 | $6.12 | 92.52K |
| Oct 16, 2026 | $6.67 | $7.05 | $5.82 | $5.92 | 153.37K |
| Oct 15, 2026 | $6.30 | $6.8699 | $6.30 | $6.74 | 72.33K |
| Oct 14, 2026 | $6.16 | $6.47 | $6.0001 | $6.36 | 20.35K |
| Oct 13, 2026 | $6.33 | $6.51 | $6.00 | $6.10 | 23.6K |
| Oct 12, 2026 | $7.01 | $7.13 | $6.10 | $6.33 | 138.13K |
| Oct 9, 2026 | $5.71 | $7.09 | $5.61 | $6.73 | 207.79K |
| Oct 8, 2026 | $5.81 | $6.1999 | $5.53 | $5.79 | 148.95K |
| Oct 7, 2026 | $6.22 | $6.38 | $5.6324 | $5.88 | 135.93K |
| Oct 6, 2026 | $6.94 | $7.10 | $5.20 | $6.15 | 439.69K |
Latest YDES news
The latest Smart Investors Daily articles mentioning YDES.
Stock researchCompany · Overview
Company
Market Activity
Research & News
YDES research
Overview
Company profile and research snapshot.
Company profile
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Aug 25, 2026
YD Bio Publishes Review Article Titled Beyond Bone Health: Exploring The ‘Heart–Brain–Bone’ Axis Modulated By Lipid-Soluble Nutrients
YD Bio Limited ("YD Bio" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced the
Benzinga · Jul 7, 2026
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's after-market session. The company's market cap stands at $2.0 million. Ironwood Pharmaceuticals (NASDAQ:IRWD)
ChartMill · Jul 7, 2026
Which stocks have an unusual volume on Tuesday?
Unusual volume stocks in Tuesday's session
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
